p.360 抽出テキスト

morphine. Clin Pharmacokinet 1993; 24: 413‒20 3) Tiseo PJ, Thaler HT, Lapin J, et al. Morphine‒6‒glucuronide concentrations and opioid‒related side effects: a survey in cancer patients. Pain 1995; 61: 47‒54 4) Ashby M, Fleming B, Wood M, et al. Plasma morphine and glucuronide(M3G and M6G) concentrations in hospice inpatients. J Pain Symptom Manage 1997; 14: 157‒67 5) Wood MM, Ashby MA, Somogyi AA, et al. Neuropsychological and pharmacokinetic assessment of hospice inpatients receiving morphine. J Pain Symptom Manage 1998; 16: 112‒20 6) Lee MA, Leng ME, Tiernan EJ. Retrospective study of the use of hydromorphone in palliative care patients with normal and abnormal urea and creatinine. Palliat Med 2001; 15: 26‒34 7) Riley J, Ross JR, Rutter D, et al. A retrospective study of the association between haematological and biochemical parameters and morphine intolerance in patients with cancer pain. Palliat Med 2004; 18: 19‒24 8) Riley J, Ross JR, Rutter D, et al. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer 2006; 14: 56‒64 9) Narabayashi M, Saijo Y, Takenoshita S, et al. Opioid rotation from oral morphine to oral oxycodone in cancer patients with intolerable adverse effects: an open‒label trial. Jpn J Clin Oncol 2008; 38: 296‒304 10) Paramanandam G, Prommer E, Schwenke DC. Adverse effects in hospice patients with chronic kidney disease receiving hydromorphone. J Palliat Med 2011; 14: 1029‒33 11) Melilli G, Samolsky Dekel BG, Frenquelli C, et al. Transdermal opioids for cancer pain control in patients with renal impairment. J Opioid Manag 2014; 10: 85‒93 12) Kurita GP, Lundström S, Sjøgren P, et al. Renal function and symptoms/adverse effects in

opioid‒treated patients with cancer. Acta Anaesthesiol Scand 2015; 59: 1049‒59

【参考文献】a) Sande TA, Laird BJ, Fallon MT. The use of opioids in cancer patients with renal impairment‒ a systematic review. Support Care Cancer 2017; 25: 661‒75 b) King S, Forbes K, Hanks GW, et al. A systematic review of the use of opioid medication for those with moderate to severe cancer pain and renal impairment: a European Palliative Care Research Collaborative opioid guidelines project. Palliat Med 2011; 25: 525‒52 c) Caraceni A, Hanks G, Kaasa S, et al.; European Palliative Care Research Collaborative

(EPCRC); European Association for Palliative Care(EAPC). Use of opioid analgesics in the treatment of cancer pain: evidence‒based recommendations from the EAPC. Lancet Oncol 2012; 13: e58‒68 d) 薬剤性腎障害診療ガイドライン 2016. 日腎会誌 2016; 58: 477‒555. https://cdn.jsn.or.jp/academicinfo/report/CKD‒guideline2016.pdf(2019 年9 月18 日閲覧) III章推奨